This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
Home
>
Mental health
Mental health
Actavis brings escitalopram to market
Study in cocaine dependence completes enrolment ahead of schedule
Study shows schizophrenia hospitalisation reduction rate
Lundbeck and Otsuka to co-develop vaccine for Alzheimer’s
Brintellix® improvement in adult patients with major depression
Treating alcohol misuse disorders
Abilify Maintena® approved in Europe for maintenance treatment of schizophrenia
Phase III clinical trials for Alzheimer’s disease
Paliperidone palmitate: efficacy and cost effectiveness
Takeda and Lundbeck announce FDA approval of Brintellix™
Lundbeck raises expectations for 2013
Lu AE58054 as add-on to donepezil
« Previous
1
…
6
7
8
9
10
…
26
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: